e-learning
resources
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
Estee P.M. Lau, Matin Eshraghi, Kirstie Dootson, Cindy Yeoh, Wint Ywe Phu, Y.C. Gary Lee, Natalia D. Popowicz
Source:
ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Estee P.M. Lau, Matin Eshraghi, Kirstie Dootson, Cindy Yeoh, Wint Ywe Phu, Y.C. Gary Lee, Natalia D. Popowicz. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection. ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
Source: ERJ Open Res, 5 (3) 00084-2019; 10.1183/23120541.00084-2019
Year: 2019
Variable adoption of intrapleural fibrinolytic therapy for pleural space infections
Source: International Congress 2018 – Pleural interventions
Year: 2018
Intrapleural use of dornase alfa and tissue plasminogen activator are successful as treatment in pediatric empyema: a pilot study
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018
The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients.
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005
A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS)
Source: Virtual Congress 2021 – Novelties in interventional pulmonology
Year: 2021
Effectiveness and safety of tissue plasminogen activators (t-PA) in complicated pleural effusion (CPE), what the correlation with time it stays in the pleural space?
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Outcomes of intrapleural tissue plasminogen activator (tPA) and deoxyribnuclease (DNase) for IPC-related pleural infection
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010
Safety and efficacy of reduced dose intrapleural alteplase and DNAase for pleural infection
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Intrapleural urokinase in the management of empyema in children
Source: Eur Respir J 2004; 24: Suppl. 48, 620s
Year: 2004
Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001
Intrapleural fibrinolytic treatment of empyemas
Source: Eur Respir J 2005; 26: Suppl. 49, 491s
Year: 2005
Efficacy of thrombolytic agents in the treatment of pulmonary embolism
Source: Eur Respir J 2005; 26: 864-874
Year: 2005
Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Primary thoracoscopy versus fibrinolysis in the management of pleural sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 51s
Year: 2004
Multicenter review suggests tunneled pleural catheter use in antineoplastic therapy-related immunosuppression does not increase infection rate
Source: International Congress 2018 – Pleural interventions
Year: 2018
Ten years experience of use of intrapleural streptokinase (IPSK) for empyema
Source: Eur Respir J 2001; 18: Suppl. 33, 319s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept